Neurogene Inc (NGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Operating Expenses | 5,592 | 4,917 | 4,792 | 6,039 | 7,818 |
| Operating Income | -5,592 | -4,917 | -4,792 | -6,039 | -7,818 |
| Other Income | -71 | -118 | 42 | -373 | -273 |
| Pre-tax Income | -5,663 | -5,035 | -4,750 | -6,412 | -8,091 |
| Net Income Continuous | -5,663 | -5,035 | -4,750 | -6,412 | -8,091 |
| Net Income | $-5,663 | $-5,035 | $-4,750 | $-6,412 | $-8,091 |
| EPS Basic Total Ops | -5.20 | -8.60 | -8.80 | -12.00 | -7.40 |
| EPS Basic Continuous Ops | -5.26 | -8.50 | -8.86 | -11.97 | -6.67 |
| EPS Diluted Total Ops | -5.20 | -8.60 | -8.80 | -12.00 | -7.40 |
| EPS Diluted Continuous Ops | -5.26 | -8.50 | -8.86 | -11.97 | -6.67 |
| EBITDA(a) | $-5,592 | $-4,917 | $-4,792 | $-6,039 | $-7,818 |